Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Eileen M. O'Connor"'
Autor:
J. Steven Alexander, Peter O. Behan, Aimee Borazanci, Isabel Bosca, Hermine Brunner, Abhijit Chaudhuri, Tiffany Chang, Andrew L. Chesson, Xi Chen, Paweł Cieślik, Randall J. Cohrs, Natalie Cornay, Robin Davis, Francesco Deleo, Gabriele Di Comite, Ludovico D’Incerti, Donard S. Dwyer, Masoud Etemadifar, Clare Fraser, Don Gilden, Gavin Giovannoni, Eduardo Gonzalez-Toledo, D.Neil Granger, Viktoria Gudi, Meghan Harris, Antoni Hrycek, Stephen Jaffe, Edward Johnson, Roger E. Kelley, Marisa Klein-Gitelman, Cesar Liendo, Alexandra Lopez-Soriano, Amy E. Lovett-Racke, Amir-Hadi Maghzi, Monica Marta, Ravi Mahalingam, Nicholas E. Martinez, Rae Ann Maxwell, Jeanie McGee, David E. McCarty, Ute-Christiane Meier, Mandana Mohyeddin Bonab, Alireza Minagar, Mutsumi Nagai, Maria A. Nagel, Behrouz Nikbin, Eileen M. O’Connor, Seiichi Omura, Magdalena Olszanecka-Glinianowicz, Parrin Patterson, Gordon T. Plant, Refik Pul, Brain Rubin, Amy C. Rauchway, Michael K. Racke, Mohammad-Reza Savoj, Fumitaka Sato, Robert N. Schwendimann, Yadollah Shakiba, Thomas Skripuletz, Karen Small, Martin Stangel, Malú G. Tansey, Corinna Trebst, Ikuo Tsunoda, Elke Voss, Yuhong Yang, Robert Zivadinov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::91cfd70f0404c8f54e6c13bac6e7c62b
https://doi.org/10.1016/b978-0-12-384913-7.00025-3
https://doi.org/10.1016/b978-0-12-384913-7.00025-3
Autor:
Rae Ann Maxwell, Eileen M. O’Connor
Publisher Summary Natalizumab (Tysabri™) is a humanized anti-integrin monoclonal antibody used for treatment of multiple sclerosis (MS) and Crohn's disease. Natalizumab is a selective adhesion molecule (SAM) inhibitor therapy targeting the a-4 comp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::983048fe17280b9e15bfadb1fe20fefc
https://doi.org/10.1016/b978-0-12-384913-7.00008-3
https://doi.org/10.1016/b978-0-12-384913-7.00008-3
Autor:
John M. Dempster, Robert N Schwendimann, Uma Menon, Vivek Misra, Alireza Minagar, J. Steven Alexander, Eduardo Gonzalez-Toledo, Romy Hoque, Stacy J. Smith, Meghan Kenner, Eileen M. O’Connor, Roger E. Kelley, Elena Korniychuk
The introduction of immunomodulatory and immunosuppressive agents for treatment of multiple sclerosis (MS) has forever altered the natural course of this incurable and disabling neurodegenerative disorder. Despite early diagnosis of relapsing‐remit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::efce5df677cc2c01e082330d87dcb7d0
https://doi.org/10.1016/s0074-7742(07)79025-6
https://doi.org/10.1016/s0074-7742(07)79025-6
Publikováno v:
Journal of Agricultural and Food Chemistry. 17:10-14
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ad8c46f0c55b9822993dbd9e16b48311
https://doi.org/10.1021/jf60161a004
https://doi.org/10.1021/jf60161a004
